Clinical Trials Sponsored by Juno

Total 263 results

Celgene
Juno

Withdrawn

A Study to Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia (ORBIT)

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Belgium, France, Spain, Italy, Germany, Switzerland, United Kingdom
Juno Therapeutics, a Subsidiary of Celgene

Active, not recruiting

A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma

Multiple Myeloma

United States
Juno Therapeutics, a Subsidiary of Celgene

Active, not recruiting

A Study of CC-98633, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma

Multiple Myeloma

United States
Juno Therapeutics, a Subsidiary of Celgene

Terminated

Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product

Follicular Lymphoma | Multiple Myeloma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma

United States
Juna d.o.o.

Unknown

Safety and Efficacy of Laser Therapy in Gynaecology

Cervical Intraepithelial Neoplasia | Hidradenitis Suppurativa | Lichen Sclerosus | Herpes Genitalis | Genital Wart | Labial Reduction Surgery | Episiotomy Scar | Bartholin Cyst

Slovenia
Juna d.o.o.

Completed

Er:YAG Laser Treatment for Female Stress and Mixed Urinary Incontinence (IncontiLase)

Female Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
Juno Therapeutics, a Subsidiary of Celgene

Active, not recruiting

Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)

Follicular Lymphoma | Non-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal B-cell Lymphoma | Mantle-cell Lymphoma

United States
Juno Therapeutics, a Subsidiary of Celgene

Completed

Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006)

Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, Nonhodgkin

United States
Juno Therapeutics, a Subsidiary of Celgene

Available

Nonconforming Lisocabtagene Maraleucel Expanded Access Protocol

Lymphoma, Large B-Cell, Diffuse
Juno Therapeutics, a Subsidiary of Celgene

Completed

Study Evaluating the Safety and Efficacy of JCARH125 in Subjects With Relapsed and/or Refractory Multiple Myeloma (EVOLVE)

Multiple Myeloma

United States
Juno Therapeutics, a Subsidiary of Celgene

Active, not recruiting

Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Leukemia, Lymphocytic, Chronic, B-Cell | Lymphoma, Small Lymphocytic

United States
Juno Therapeutics, a Subsidiary of Celgene

Active, not recruiting

A Study of CC-97540, CD19-targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Lymphoma Non-Hodgkin | Agressive Lymphoma | Diffuse-large B-cell Lymphoma (DLBCL)

United States, Canada
Juno Therapeutics, a Subsidiary of Celgene

Completed

Long-Term Follow-up Study for Patients Previously Treated With JCAR015

Acute Lymphoblastic Leukemia

United States
Juno Therapeutics, a Subsidiary of Celgene

Terminated

Study Evaluating the Efficacy and Safety of JCAR015 in Adult B-cell Acute Lymphoblastic Leukemia (B-ALL) (ROCKET)

Acute Lymphoblastic Leukemia

United States
Juno Therapeutics, Inc., a Bristol-Myers Squibb...

Recruiting

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

Relapsed and/or Refractory Multiple Myeloma

United States, France, Spain, Germany
Memorial Sloan Kettering Cancer Center
Juno Therapeutics, Inc.

Active, not recruiting

A Trial of "Armored" CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies

Chronic Lymphocytic Leukemia (CLL) | Refractory | Relapsed

United States
Juno Therapeutics, Inc., a Bristol-Myers Squibb...

Recruiting

Study of BMS-986393 a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma (QUINTESSENTIAL)

Multiple Myeloma

United States, Canada
Juno Therapeutics, Inc., a Bristol-Myers Squibb...

Recruiting

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of BMS-986393 in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

Multiple Myeloma

United States
Jung Im Jung
Taejoon Pharmaceutical Co., Ltd.

Recruiting

Chest CT Using Low-concentration Iodine Contrast Media

Pulmonary Disease

Korea, Republic of
Ge Junbo

Terminated

Effect of Low-dose Intracoronary Reteplase on Myocardial Infarct Size During Primary Percutaneous Coronary Intervention (RECOVERII)

Acute ST-segment Elevation Myocardial Infarction

China
Juno Therapeutics, a Subsidiary of Celgene
Bristol-Myers Squibb

Completed

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

Neoplasms | Neoplasms by Histologic Type | Lymphoma | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin | Immune System Disorder

United States
Eun Jung Kim
DongGuk University

Unknown

The Efficacy and Safety of Cettum for Perennial Allergic Rhinitis

Rhinitis, Allergic
Eun Jung Kim
DongGuk University

Unknown

Efficacy and Safety of Cettum for Knee Osteoarthritis

Osteoarthritis, Knee

Korea, Republic of
Eun Jung Kim

Unknown

A Clinical Study About Improvement of Chronic Fatigue After Taking Red Ginseng

Chronic Fatigue Syndrome

Korea, Republic of
Juno Therapeutics, Inc., a Bristol-Myers Squibb...
Celgene Corporation

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma

Relapsed or Refractory Follicular Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb...
Celgene Corporation

Recruiting

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis or Progressive Forms of Multiple Sclerosis

Multiple Sclerosis

United States, Belgium, France, Germany, Spain, United Kingdom, Italy
Juno Therapeutics, Inc., a Bristol-Myers Squibb...
Celgene Corporation

Withdrawn

A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies

Leukemia, Lymphocytic, Chronic, B-Cell

United States, Austria, Belgium, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, United Kingdom
Memorial Sloan Kettering Cancer Center
Stanford University; Juno Therapeutics, Inc.

Active, not recruiting

Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors

Solid Tumors

United States
Jun Wang

Recruiting

Thymosin Alpha-1 for irAE Secondary to ICIs

IrAE

China
Jun Zhang

Completed

Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer

Advanced Ovarian Cancer

China
Jun Zhu

Unknown

A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation

Vomiting
IVI Vigo
Instituto Valenciano de Infertilidad, IVI VALENCIA; Juno Therapeutics, Inc.

Not yet recruiting

Embryos With Preimplantation Genetic Testing for Aneuploidies (PGT-A) Inconclusive Result: Clinical Implications

Embryo Disorder
Jung-min Ahn

Recruiting

Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement (RENOVATE)

Thromboembolism | AORTIC VALVE DISEASES

Korea, Republic of
Seung-Jung Park

Completed

The Registry Study to Compare the Cardiopulmonary Exercise Test Parameters Before and After Cardiac Rehabilitation in Patients With Chronic Total Occlusion of the Coronary Arteries

Coronary Artery Disease | Total Occlusion of Coronary Artery

Korea, Republic of
Jun Zhang

Recruiting

Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy

Breast Cancer | Sentinel Lymph Node Biopsy | Breast-Conserving Surgery | Pectoral Nerves Block

China
Jun Zhang

Completed

A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China

Congenital Cytomegalovirus Infection

China
Jun Zhang

Completed

The Epidemiologic Study of Human Cytomegalovirus（CMV） in Female Students of Xiamen University

Cytomegalovirus Infections

China
Jun Zhu

Unknown

MT-R Followed by Autologous Stem Cells Transplantation in Newly-diagnosed Primary Central Nervous System Lymphoma

Primary Central Nervous System Lymphoma

China
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); Juno Therapeutics, Inc.

Completed

Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
Jung-min Ahn

Recruiting

Genome-wide Association Study of Development of Collateral Circulation for Patients With Coronary or Peripheral Artery Disease (GWAScollateral)

Coronary Disease | Peripheral Arterial Disease | Collateral Circulation, Any Site

Korea, Republic of
Seung-Jung Park

Recruiting

Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)

Coronary Artery Disease

Korea, Republic of
Ge Junbo
RainMed Medical

Completed

A Prospective, Multi-center Clinical Trial for Evaluating the Effectiveness and Safety of Online Coronary Angiography-Derived Index of Microcirculatory Resistance (caIMR) (Flash III)

Coronary Microvascular Dysfunction

China
Chang Wei-Jung

Completed

Outcome After Laparoscopic Surgery for Peptic Ulcer Perforation

Pneumonia | Intraabdominal Abscess After Procedure | Leakage | Operation Wound; Infection
Camille JUNG

Terminated

Study of Psychomotor Development and Attachment in Children Aged 6 to 30 Months With Oral Disorder (TODEVA)

Eating Disorders in Children | Psychomotor Development Impaired

France
Camille JUNG

Completed

Impact of Antibiotic Treatment of Group A Streptococcal Blistering Distal Dactylitis in Children (TAPPS)

Blistering Distal Dactylitis

France
Seung-Jung Park

Completed

Coronary Spasm Presenting Aborted Sudden Cardiac Death, the Multicenter Registry

Coronary Vasospasm | Cardiac Death

Korea, Republic of
Gao-jun Teng

Recruiting

TACE With Dicycloplatin(TP21) in Unresectable HCC

Hepatocellular Carcinoma

China
Li-jun Ding

Recruiting

Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency

Premature Ovarian Insufficiency

China
Xian-Jun Yu

Not yet recruiting

he Safety Research of Timing of the Removal of Abdominal Drains After Pancreatic Surgery

Safety Issues

China
Hai-Jun Wang

Completed

Body Constitution Classification Based Comprehensive Health Management Intervention on Obese Population

Obesity | Overweight

China

Clinical Trials Sponsored by Juno

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations